Company Clearmind Medicine Inc.

Equities

CMND

CA1850534027

Biotechnology & Medical Research

Market Closed - Nasdaq 03:42:35 2024-06-10 pm EDT Pre-market 07:59:47 am
1.02 USD -1.21% Intraday chart for Clearmind Medicine Inc. 1.175 +15.20%

Business Summary

Clearmind Medicine Inc. is a psychedelic pharmaceutical biotech company. The Company is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The Company researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company’s intellectual portfolio consists of 15 patent families, including 27 granted patents and 24 pending applications. The portfolio spans a range of jurisdictions, including the United States, Europe, India, and China.

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 3,169,614 3,169,614 ( 100.00 %) 0 100.00 %

Shareholders

NameEquities%Valuation
187,500 5.916 % 211 875 $
Iroquois Capital Management LLC
3.944 %
125,000 3.944 % 141 250 $
AdvisorShares Investments LLC
3.555 %
112,693 3.555 % 127 343 $
AdvisorShares Investments LLC
2.924 %
92,693 2.924 % 104 743 $
37,638 1.187 % 42 531 $
G1 Execution Services LLC
0.7566 %
23,981 0.7566 % 27 099 $
Geode Capital Management LLC
0.5122 %
16,234 0.5122 % 18 344 $
7,692 0.2427 % 8 692 $
6,262 0.1976 % 7 076 $
3,333 0.1052 % 3 766 $

Company contact information

Clearmind Medicine, Inc.

1220 West 6th Avenue Suite 101

V6H 1A5, Vancouver

+604 260 1566

http://www.clearmindmedicine.com
address Clearmind Medicine Inc.(CMND)
  1. Stock Market
  2. Equities
  3. CMND Stock
  4. Company Clearmind Medicine Inc.